RTX Corp
RTX Corp (RTX) Stock News
The latest RTX headlines and market coverage — 10 recent stories, updated throughout the day.
- The Motley Fool·
Lockheed Martin vs. RTX: Which Defense Stock Is a Better Buy in 2026?
The article compares two major defense contractors: Lockheed Martin, which relies heavily on the F-35 program and U.S. government contracts (72% of sales), and RTX, which offers more diversification through commercial and military aerospace segments. Lockheed Martin is recommended as the better buy due to lower valuation multiples (forward P/E of 17x vs. RTX's 26.7x) and guaranteed long-term revenue from the F-35 program extending into the 2040s, despite RTX showing faster expected growth and lower debt levels.
- GlobeNewswire Inc.·Neutral
XORTX Announces Election to Voluntary Delist from the TSX Venture Exchange
XORTX Therapeutics Inc. has elected to voluntarily delist its common shares from the TSX Venture Exchange (TSXV) to reduce costs and administrative burden. The company will maintain its listings on Nasdaq and Frankfurt. The delisting is expected to eliminate duplicative exchange fees, reduce legal and accounting expenses, and allow management to focus on advancing its XRx-026 gout treatment program. Canadian shareholders will retain full trading access on Nasdaq.
- Benzinga·Neutral
SpaceX Is Worth More Than Boeing, RTX, GE Aerospace And Every Other S&P 500 Aerospace Firm Combined
SpaceX's upcoming IPO values the company at $1.77 trillion, exceeding the combined valuation of all 12 S&P 500 aerospace and defense companies (~$1.5 trillion), despite generating only $18.7 billion in revenue compared to their $500 billion combined. While analysts like Gene Munster and Ron Baron express bullish sentiment with predictions of $30 trillion future value, critics including NYU's Aswath Damodaran raise concerns about valuation and market opportunity estimates.
- Investing.com·
Nvidia Sends a Message With RTX Spark—This Is What It Says
Nvidia unveiled the RTX Spark, a superchip combining Blackwell RTX graphics, Arm CPU cores, and an NPU for personal computers, marking the company's entry into the PC market. The chip delivers petaflop AI computing power and unified memory for local AI applications. Analysts view this as part of Nvidia's broader strategy to dominate AI across all layers—data centers, edge, PCs, and IoT—with strong revenue growth expected and price targets reaching $500 within 12 months.
- GlobeNewswire Inc.·
ASUS Unveils Revolutionary ProArt P16 and P14 Laptops Powered by NVIDIA RTX Spark at Computex 2026
ASUS unveiled its new ProArt P16 and P14 laptops along with a ProArt Mini PC powered by NVIDIA's RTX Spark superchip at Computex 2026. These devices are designed for AI creators and developers, featuring up to 1 petaflop of AI performance, 128GB unified memory, and ASUS Lumina Pro OLED displays. The ecosystem integrates exclusive AI tools and partnerships with Adobe, Blackmagic Design, and Blender. Availability begins fall 2026.
- Benzinga·
MediaTek Collaborates with NVIDIA on the RTX Spark to Power the Next Wave of Windows PC Experiences
MediaTek and NVIDIA announced a collaboration on the RTX Spark, a new processor class for Windows 11 PCs designed for personal AI agents, content creation, and gaming. MediaTek contributes CPU performance, power efficiency, memory architecture, and connectivity expertise, while NVIDIA provides its AI platform and RTX technologies. The first RTX Spark-powered laptops will launch in Fall 2026, marking MediaTek's expansion from entry-level devices into the premium Windows PC market.
- GlobeNewswire Inc.·
HP Debuts PCs Built for the Next Wave of Windows PC Experiences Powered by NVIDIA RTX Spark™
HP Inc. unveiled a comprehensive portfolio of AI-enabled devices and solutions designed for developers, creators, and gamers. The announcement includes laptops powered by NVIDIA RTX Spark, the HP OmniDesk Mini Desktop PC with Thunderbolt Share, secure AI processing systems for regulated environments, and workstations featuring AMD Ryzen AI PRO processors. These devices aim to accelerate local AI processing and hybrid workflows while maintaining security and ease of setup.
- GlobeNewswire Inc.·
BioRestorative Completes Phase 2 Dosing of BRTX-100, Advancing Lead Regenerative Spine Program Toward 2027 Topline Data
BioRestorative Therapies announced completion of dosing in its Phase 2 clinical trial for BRTX-100, treating 99 patients with chronic lumbar disc disease. The randomized, double-blind, sham-controlled study has advanced to blinded follow-up with topline safety and efficacy data expected in Q2 2027. The company received FDA alignment on Phase 3 development pathway following a Type B meeting, with no clinical safety concerns raised.
- Investing.com·
Nvidia’s China Strategy Faces New Pressure After RTX 5090D V2 Ban
China banned Nvidia's RTX 5090D V2 chip, signaling a shift toward reducing dependency on U.S. semiconductors and favoring domestic alternatives. While the U.S. approved H200 sales to Chinese tech companies, no chips have been delivered due to undisclosed conditions from Beijing. Nvidia's China revenue has fallen to 5% of total sales, and the ban suggests the company's export-compliant strategy has failed at both ends—Washington restricts high-end chips while Beijing blocks lower-end alternatives.
- Seeking Alpha·Neutral
RTX secures $369.9M contract modification for the F135 engine program